Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Smartfinancial Director Steven B. Tucker Sells $173K of Stock
Steven B. Tucker, Director, sold 3,500 shares of Smartfinancial Inc. at $49.50 a share, worth $173K in total on Oct 23, 2026. Shares held after the trade: 47,222 (-6.9%).
Zeo Energy Corp. received a 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock will continue to trade on the Nasdaq Capital Market during this period while management monitors the stock price and considers options to meet the listing standard.
Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation and Bylaws in connection with the closing of its initial public offering. These governance changes were previously approved by the board and stockholders to take effect upon the IPO's completion.
Nucor Corporation reported Q3 2026 net earnings of $1.32 billion on net sales of $11.25 billion, driven by strong demand and higher average selling prices in its steel mills segment. The company generated $2.7 billion in free cash flow year-to-date and achieved operational milestones including the first heat at its West Virginia sheet mill.
Term
Q3 2026
“I want to thank our teammates for delivering another strong quarter and making 2026 the safest summer in Nucor history. Supported by robust demand across key end markets, Nucor has generated approximately $2.7 billion of free cash flow and returned nearly $1.4 billion to shareholders through the first nine months of the year.”
Leon Topalian, Nucor’s Chair and Chief Executive Officer
“We also achieved important milestones in advancing our growth strategy, including the first heat at our West Virginia sheet mill in September and the recent start-up of our second galvanizing line at Nucor Steel Berkeley. These projects, together with other recent investments, are expanding Nucor’s capabilities and strengthening our position in attractive markets.”
Leon Topalian, Nucor’s Chair and Chief Executive Officer
Bank of Hawaii reported net income of $64.3 million for the third quarter of 2026, an increase from $53.3 million in the same period of 2025. Total assets decreased slightly to $23.8 billion as of September 30, 2026, compared to $24.2 billion at year-end 2025, primarily driven by a reduction in cash and cash equivalents and held-to-maturity investment securities.
Rallybio Signs $82.7M M&A Deal with Avenzo Therapeutics, Inc.
Rallybio Corporation provided a status update on its pending merger with Avenzo Therapeutics, declaring a special cash distribution of approximately $82.7 million ($13.56 per share) to stockholders. The distribution is based on the company's estimated net cash exceeding zero prior to the merger closing and is scheduled for payment on November 13, 2026.
Apollo Asset Backed Credit Co Capital Raise of $34.7M
Apollo Asset Backed Credit Company LLC issued and sold unregistered shares across multiple classes for total aggregate consideration of approximately $34.73 million as of October 1, 2026. The company also disclosed its Transactional Net Asset Value (NAV) per share as of September 30, 2026, which serves as the pricing basis for ongoing sales and its quarterly share repurchase program.
Alpha Cognition Insider Opaleye Management Inc. Buys $266K of Stock
Opaleye Management Inc. bought 32,090 shares of Alpha Cognition Inc. at $8.23 to $8.33 a share (average $8.28) in 2 transactions, worth $266K in total between Oct 22, 2026 and Oct 23, 2026. Shares held after the trade: 3,291,984 (+0.5%).
Charles River Laboratories International Insider James C. Foster Sells $8.41M of Stock
James C. Foster sold 24,042 shares of Charles River Laboratories International, Inc. at $350.00 a share, worth $8.41M in total on Oct 22, 2026. Shares held after the trade: 31,596 (-43.2%).
Boundless Bio 10% Owner Kevin Tang Buys $51.6K of Stock
Kevin Tang, 10% Owner, bought 21,640 shares of Boundless Bio, Inc. at $2.38 to $2.40 a share (average $2.39) in 3 transactions, worth $51.6K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,011,749 (+0.3%).
Standex International Corporation appointed Brenna D. Preisser as a Class I director, effective January 1, 2027, succeeding the retiring B. Joanne Edwards. Ms. Preisser, currently an Executive Vice President at Brunswick Corporation, will receive a $150,000 restricted stock award and standard non-employee director compensation.
Genvor Incorporated entered into an Intellectual Property Assignment Agreement with its founder and Chief Scientific Officer, Dr. Jesse Jaynes. Dr. Jaynes assigned the rights to approximately 9,000 synthetic antimicrobial peptide sequences and associated validation data to the company for use in its research and commercialization programs.
Soren Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Jamie Weber. Additionally, Roger Cloutier Jr. and Austin Criden were appointed to the board following the resignations of Spencer Gerrol and Charles N. Kahn III. These changes are part of a broader alignment with the Di Rezze Family Office, which sponsors the SPAC.
Mirum Pharmaceuticals announced positive results from Cohort 2 of its pivotal PROGRESS study evaluating ATEBRIOZ (zilurgisertib) in pediatric patients aged 6 to <12 with fibrodysplasia ossificans progressiva (FOP). The study met its endpoints with a significant reduction in total heterotopic ossification lesion volume and improved joint mobility compared to placebo, supporting a planned sNDA submission in the first half of 2027.
Kinetik Holdings subsidiary EagleClaw Midstream Ventures reached a settlement with Energy Transfer to resolve a dispute regarding the expiration date of an NGL purchase agreement. The parties confirmed the agreement will terminate on December 31, 2026, while a second agreement remains subject to ongoing litigation awaiting adjudication.
Longeveron announced updated Phase 2b ELPIS II trial results for laromestrocel in infants with hypoplastic left heart syndrome (HLHS). While the trial missed its primary efficacy endpoint of RVEF change, additional analysis showed the secondary endpoint of major adverse cardiac events (MACE) achieved statistical significance with only 1 event in the treatment arm versus 8 in the standard of care arm (P=0.043).
Capital City Bank Group Director William F. Butler Buys $20K of Stock
William F. Butler, Director, bought 392 shares of Capital City Bank Group Inc at $51.07 a share, worth $20K in total on Oct 26, 2026. Shares held after the trade: 7,137 (+5.8%).
Flexsteel Industries reported fiscal first quarter 2027 net sales of $114.0 million, a 3.2% increase year-over-year, driven by 5.1% growth in Flexsteel branded products. GAAP net income per diluted share was $1.24, down from $1.31 in the prior year quarter, impacted by foreign currency headwinds and rising ocean transportation and material costs.
Term
Q1 2027
“I'm pleased with our first quarter results and the continued momentum of our growth strategies despite a challenging macroeconomic environment. Net sales increased 3.2 percent compared to the prior year, toward the upper end of our guidance range, marking our twelfth consecutive quarter of year-over-year growth.”
Derek Schmidt, CEO of Flexsteel Industries, Inc.
“From a profitability standpoint, we delivered a GAAP operating margin of approximately 6 percent, which included a $0.8 million or 70 bps unfavorable foreign currency translation impact related to our peso-denominated asset exposure in Mexico.”
GrafTech International Ltd. finalized estimates for its previously announced permanent closure of its manufacturing facility in Monterrey, Mexico. The company expects to incur total non-cash charges of $25 million to $35 million, including $12.3 million in fixed asset write-offs, while maintaining its estimate of $20 million to $25 million in one-time cash expenditures.
Supernus Pharmaceuticals Deal Termination with UBS Bank USA
Supernus Pharmaceuticals terminated its uncommitted demand revolving credit line with UBS Bank USA on October 20, 2026. The termination was made in anticipation of the company's pending merger with Indivior Pharmaceuticals and the establishment of a new senior secured credit facility for the combined entity. There were no outstanding borrowings or early termination penalties associated with the cancellation.
Columbus McKinnon Corporation's Board of Directors declared a regular quarterly cash dividend of $0.07 per common share. The dividend is payable on November 16, 2026, to shareholders of record as of November 6, 2026.
CV Sciences has settled an arbitration case initiated in February 2025 against its former legal counsel. Under the settlement terms, the company received $500,000 and both parties have mutually released all claims against each other.
Cumberland Pharmaceuticals announced plans to submit a New Drug Application (NDA) for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The submission is supported by Phase 2 FIGHT DMD trial data showing a statistically significant 5.4% improvement in left ventricular ejection fraction (LVEF) compared to a control group. While the FDA expressed concerns regarding the sufficiency of the data package for efficacy requirements, the company is moving forward with the submission following a pre-NDA meeting.
Praetorian Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Peter Ondishin. The company also appointed Roger L. Cloutier, Jimmy Vaiopoulos, and Charles P. Garcia to its board of directors following the resignations of Nicole Seligman, Erica Dorfman, and Alex Elias.
Bain Capital Private Credit declared a regular monthly distribution of $0.1875 per Class I share for shareholders of record as of October 30, 2026. The filing also disclosed a net asset value (NAV) per share of $26.03 as of September 30, 2026, and the sale of $57.0 million in unregistered shares to feeder vehicles.
Weave Communications Signs $650M M&A Deal with Francisco Partners
Weave Communications, Inc. completed its acquisition by Francisco Partners in an all-cash transaction valued at approximately $650 million. Under the terms of the deal, Weave stockholders received $7.40 per share, and the company has transitioned to a privately held entity, delisting from the New York Stock Exchange.
Value
$650M
Counterparty
Francisco Partners
“Today marks the start of an exciting new chapter for Weave. For nearly two decades, Weave has built solutions for independent practices caring for patients in communities across the country. Today, more than 40,000 locations rely on us to deepen their relationship with patients through automated communication and engagement solutions. With Francisco Partners’ support and resources, we’re well positioned to deliver even more value to the practices we serve. I want to thank our employees, whose dedication made this milestone possible.”
Brett White, Chief Executive Officer of Weave
“Weave sits at the center of how tens of thousands of healthcare practices communicate with their patients and collect revenue. We are pleased to officially partner with Brett and the Weave team and see significant opportunity to build on that position through continued product innovation in AI-powered patient engagement and payments solutions.”
Atlantic Union Bankshares EVP Matthew L. Linderman Sells $310K of Stock
Matthew L. Linderman, EVP, sold 7,746 shares of Atlantic Union Bankshares Corp at $40.00 a share, worth $310K in total on Oct 22, 2026. Shares held after the trade: 10,455 (-42.6%).
FirstSun Capital Bancorp reported Q3 2026 net income of $38.4 million, or $0.82 per diluted share, reflecting improved net interest margins and operating synergies from its recent acquisition of First Foundation. The company also completed a core system conversion for First Foundation and repurchased $49.7 million of its own common stock during the quarter.
Term
Q3 2026
“Third quarter results reflect our continued progress on our strategic priorities highlighted by an improved net interest margin as a result of continued balance sheet improvements, a strong diversified revenue profile and improved earnings performance, including benefits from operating synergies realized following the acquisition of First Foundation in the second quarter.”
Neal Arnold, FirstSun’s Chief Executive Officer and President
“Additionally, in late September, we successfully completed the core system conversion of First Foundation, representing another important milestone in our overall integration plan. I'm extremely proud of our teammates for all the hard work, planning and collaboration in completing the conversion while continuing to serve our great clients throughout the process.”
Neal Arnold, FirstSun’s Chief Executive Officer and President
TrueBlue, Inc. has appointed Elizabeth Castro Gulacsy to its Board of Directors and its Audit Committee, effective October 26, 2026. Ms. Castro Gulacsy, the former CFO of United Parks & Resorts, joins as an independent director as part of a board refreshment process and a previously disclosed cooperation agreement with EHS Management. Her appointment increases the total number of directors on the TrueBlue board to ten.
HPS Corporate Lending Fund declared regular and variable supplemental distributions for October 2026 across all share classes, payable to shareholders of record as of October 31, 2026. The total net distribution for Class I shares is $0.1990 per share, with payments expected on or about November 30, 2026. The Fund also reported a net asset value (NAV) of $24.45 per share for all classes as of September 30, 2026.